Boston Scientific Inc. (BSX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Michael F. Mahoney
Employees:
45,000
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234
508-683-4000

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions.

Data derived from most recent annual or quarterly report
Market Cap 77.593 Billion Shares Outstanding1.438 Billion Avg 30-day Volume 8.736 Million
P/E Ratio91.4818 Dividend Yield0.0 EPS0.17
Price to Revenue5.878 Debt to Equity0.4897 EBITDA2.943 Billion
Price to Book Value4.3216 Operating Margin13.626900000000001 Enterprise Value87.652 Billion
Current Ratio1.29 EPS Growth0.034 Quick Ratio0.561
1 Yr BETA 0.5877 52-week High/Low 55.38 / 37.75 Profit Margin6.806
Operating Cash Flow Growth78.2718 Free Cash Flow to Firm (FCFF) TTM -64.563 Million Free Cash Flow to Equity (FCFE) TTM608.437 Million
Altman Z-Score3.7385
Earnings Report2023-10-26
View SEC Filings from BSX instead.

View recent insider trading info

Boston Scientific Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BSX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BSX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-21 by FITZGERALD JOSEPH MICHAEL
  • 4: filed on 2023-09-15 by CARRUTHERS WENDY
  • 4: filed on 2023-09-12 by MAHONEY MICHAEL F
  • 4: filed on 2023-09-01 by MAHONEY MICHAEL F
  • 4: filed on 2023-08-30 by MIRVISS JEFFREY B.
  • 4: filed on 2023-08-28 by BROWN VANCE R
  • 4: filed on 2023-08-22 by BUTCHER ARTHUR C
  • 4: filed on 2023-08-18 by DOCKENDORFF CHARLES J
  • 4: filed on 2023-08-15 by CARRUTHERS WENDY
  • 4: filed on 2023-08-03 by MONSON JONATHAN

    • Events (8k)

  • 8-K: filed on 2023-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-06:
    Item 8.01: Other Events
  • 8-K: filed on 2023-05-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-31:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-23:
  • 144: filed on 2023-05-16:
  • 144: filed on 2023-05-15:
  • 144: filed on 2023-05-02:
  • 144: filed on 2023-04-17:
  • 144: filed on 2023-06-07:
  • 144: filed on 2023-06-15:
  • 144: filed on 2023-06-21:
  • 144: filed on 2023-07-17:
  • 144: filed on 2023-08-15:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    210.6 Thousand total shares from 9 transactions

    Exercise Derivative Conversion (M)

    127.3 Thousand total shares from 7 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FITZGERALD JOSEPH MICHAEL EVP & GROUP PRES, CARDIOLOGY

    • Officer
    		 270,356 2023-09-20 9

    CARRUTHERS WENDY EVP, HUMAN RESOURCES

    • Officer
    		 57,058 2023-09-15 15

    MAHONEY MICHAEL F CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    		 1,675,167 2023-09-12 9

    MIRVISS JEFFREY B. EVP&PRES, PERIPH INTERVENT

    • Officer
    		 60,588 2023-08-28 12

    BROWN VANCE R SVP, GC AND CORP. SECRETARY

    • Officer
    		 28,578 2023-08-25 7

    BUTCHER ARTHUR C EVP& GRP PRES, MEDSURG & APAC

    • Officer
    		 13,940 2023-08-21 10

    DOCKENDORFF CHARLES J

    • Director
    		 63,948 2023-08-18 2

    MONSON JONATHAN SVP, GLOBAL CONTROLLER AND CAO

    • Officer
    		 35,874 2023-08-02 8

    MEGA JESSICA L

    • Director
    		 3,253 2023-07-03 2

    MORANO SUSAN E

    • Director
    		 2,082 2023-07-03 2

    LUDWIG EDWARD J

    • Director
    		 0 2023-05-04 1

    FUJIMORI YOSHIAKI

    • Director
    		 0 2023-05-04 1

    ROUX DAVID J

    • Director
    		 73,591 2023-05-04 1

    WICHMANN DAVID S

    • Director
    		 36,600 2023-05-04 2

    ZANE ELLEN M

    • Director
    		 45,629 2023-05-04 1

    SUNUNU JOHN E

    • Director
    		 49,741 2023-05-04 1

    CONNORS NELDA J

    • Director
    		 36,069 2023-05-04 2

    SORENSON JOHN BRADLEY EVP, GLOBAL OPERATIONS

    • Officer
    		 36,689 2023-05-02 7

    THEPAUT ERIC FRANCIS YVES EVP & PRES, EUR, MID-EAST, AFR

    • Officer
    		 12,269 2023-05-02 9

    BRENNAN DANIEL J. EVP AND CFO

    • Officer
    		 225,958 2023-03-01 6

    JAMES DONNA

    • Director
    		 28,124 2022-05-05 0

    SCANLON MEGHAN SVP,PRES,UROLOGY PELVIC HEALTH

    • Officer
    		 26,523 2022-05-01 0

    EDDY JODI EUERLE SVP, CHIEF INFO & DIGITAL OFF.

    • Officer
    		 23,263 2022-04-01 0

    OLSON SCOTT SVP & PRES, CRM, DIAGNOSTICS

    • Officer
    		 14,518 2022-04-01 0

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    • Officer
    		 28,082 2022-03-28 0

    NANAVATY MAULIK SVP & PRES, NEUROMODULATION

    • Officer
    		 177,258 2022-02-28 0

    PIERCE DAVID A EVP PRES MEDSURG

    • Officer
    		 1,726 2022-02-28 0

    MACKEY EDWARD F EVP, OPERATIONS

    • Officer
    		 52,944 2022-02-28 0

    RALLS-MORRISON DESIREE SVP, GC AND CORP SECRETARY

    • Officer
    		 38,598 2021-02-21 0

    MACMILLAN STEPHEN P

    • Director
    		 8,000 2020-10-01 0

    BALLINGER KEVIN J. EVP & PRES, INTERVEN CARDIO

    • Officer
    		 80,085 2020-03-03 0

    WANG XIN WARREN SVP AND PRES, ASIA PACIFIC

    • Officer
    		 No longer subject to file 2020-02-15 0

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    • Officer
    		 6,348 2019-02-28 0

    PHALEN MICHAEL P. EVP & PRESIDENT, MEDSURG

    • Officer
    		 133,373 2018-02-28 0

    PRATT TIMOTHY A. EVP, GC & CHIEF ADMIN OFFICER

    • Officer
    		 154,681 2017-12-01 0

    BOSE SUPRATIM EVP & PRESIDENT, ASIA-PACIFIC

    • Officer
    		 320,301 2017-10-03 0

    DAWKINS KEITH D EVP, GLOBAL CHIEF MED. OFF.

    • Officer
    		 68,165 2017-02-28 0

    JOHNSON KRISTINA M

    • Director
    		 8,494 2016-05-03 0

    NICHOLAS PETER M

    • Director
    		 7,406,541 2016-04-01 0

    NICHOLAS NJ JR

    • Director
    		 0 2016-04-01 0

    PRANGE KAREN SVP&PRES, URO & PELVIC HEALTH

    • Officer
    		 39,395 2016-03-08 0

    MARIO ERNEST

    • Director
    		 86,032 2015-11-16 0

    ABELE JOHN E

    • DIRECTOR EMERITUS
    		 592,983 2015-08-20 0

    LANCE JEAN FITTERER SVP, ASST GC, BUS & REGIONS

    • Officer
    		 125,690 2015-02-16 0

    ONUSCHECK JOHN MICHAEL SVP & PRESIDENT, EUROPE

    • Officer
    		 116,025 2015-01-01 0

    BYRNES BRUCE L

    • Director
    		 112,097 2014-10-31 0

    REINHARDT UWE E

    • Director
    		 164,379 2014-10-31 0

    PUCEL KENNETH EVP, GLOB OPS, QUAL & TECH

    • Officer
    		 128,517 2014-02-28 0

    CAPELLO JEFFREY D EVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 447 2013-11-27 0

    BARTLETT KATHARINE T

    • Director
    		 52,464 2013-05-07 0

    SPRIGGS OTHA T. III SVP, HUMAN RESOURCES

    • Officer
    		 No longer subject to file 2012-09-07 0

    KUCHEMAN WILLIAM CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 180,828 2012-07-31 0

    NEUMANN LAWRENCE R SVP, SPECIAL PROJECTS

    • Officer
    		 77,879 2012-05-10 0

    BURNS BRIAN R EVP - GLOBAL QUALITY & REG AFF

    • Officer
    		 84,188 2012-02-28 0

    ELLIOTT JOHN RAYMOND

    • Director
    		 0 2012-02-27 0

    PEDERSEN JOHN B. PRES, URO & WOMEN'S HEALTH

    • Officer
    		 No longer subject to file 2012-02-16 0

    MORECI STEPHEN F SVP, GLOBAL SALES OPERATIONS

    • Officer
    		 44,579 2011-07-01 0

    LENO SAM R EVP & CHIEF OPERATIONS OFFICER

    • Officer
    		 432,240 2011-06-06 0

    GROVES RAY J

    • Director
    		 0 2011-03-31 0

    MILANI ANDREW N

    • FORMER SVP, HUMAN RESOURCES
    		 No longer subject to file 2010-12-31 0

    FOX MARYE ANNE

    • Director
    		 0 2010-05-11 0

    COLEN FRED EVP & CHIEF TECHNOLOGY OFFICER

    • Officer
    		 73,404 2010-05-10 0

    PEPPER JOHN E

    • Director
    		 0 2010-03-31 0

    GILBERT JAMES EVP, STRATEGY & BUSINESS DEV

    • Officer
    		 0 2010-02-26 0

    PAUL DONOVAN SVP, CORPORATE COMMUNICATIONS

    • Officer
    		 No longer subject to file 2010-02-12 0

    MCFAUL DAVID W SVP, INTERNATIONAL

    • Officer
    		 No longer subject to file 2010-02-12 0

    MCCONNELL WILLIAM F JR SVP, ADMINISTRATION CRM

    • Officer
    		 88,082 2009-07-24 0

    BAIM DONALD S EVP, CHIEF MED. & SCI. OFFICER

    • Officer
    		 53,788 2009-07-10 0

    QUINN LUCIA LUCE EXEC. VICE PRESIDENT-HR

    • Officer
    		 49,809 2009-07-01 0

    RUDMAN WARREN B

    • Director
    		 0 2009-05-05 0

    BURNS URSULA M

    • Director
    		 32,001 2009-05-05 0

    TOBIN JAMES R PRESIDENT & CEO

    • Officer
    • Director
    		 0 2009-02-24 0

    LAVIOLETTE PAUL A COO

    • Officer
    		 No longer subject to file 2008-07-01 0

    FLEISHMAN JOEL LAWRENCE

    • Director
    		 143,941 2008-05-06 0

    DEPARLE NANCY ANN

    • Director
    		 13,886 2008-05-06 0

    SANDMAN PAUL W EVP AND GENERAL COUNSEL

    • Officer
    		 No longer subject to file 2008-02-29 0

    PROMERICA LP

    • 10% Owner
    		 54,635,185 2007-08-07 0

    BEST LAWRENCE C EVP

    • Officer
    		 285,838 2007-07-06 0

    GOODMAN JEFFREY H SVP, INTERNATIONAL

    • Officer
    		 68,460 2007-07-01 0

    BARTELL MARK C SVP GLOBAL SALES/MKT CRM

    • Officer
    		 50,619 2007-05-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    FITZGERALD JOSEPH MICHAEL - Officer EVP & GROUP PRES, CARDIOLOGY

    		2023-09-21 16:09:49 -0400 2023-09-20 S 15,867 $55.00 d 197,992 direct yes

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-09-15 18:34:47 -0400 2023-09-15 S 11,671 $53.95 d 57,058 direct yes 0.0566 0.0566 2 0.0 1

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-09-15 18:34:47 -0400 2023-09-15 M 3,448 d 10,346 direct yes

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-09-15 18:34:47 -0400 2023-09-15 M 3,448 $16.31 a 65,769 direct yes 0.0566 0.0566 2 0.0 1

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-09-15 18:34:47 -0400 2023-09-15 M 2,960 d 8,879 direct yes

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-09-15 18:34:47 -0400 2023-09-15 M 2,960 $13.08 a 68,729 direct yes 0.0566 0.0566 2 0.0 1

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-12 17:37:35 -0400 2023-09-12 S 113,355 $53.91 d 1,498,922 direct yes -0.5263 1.6917 1.6917 6 -0.5639 3

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-12 17:37:35 -0400 2023-09-12 M 57,680 d 115,361 direct yes

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-12 17:37:35 -0400 2023-09-12 M 57,680 $13.08 a 1,556,602 direct yes -0.5263 1.6917 1.6917 6 -0.5639 3

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-12 17:37:35 -0400 2023-09-12 M 55,675 d 278,376 direct yes

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-12 17:37:35 -0400 2023-09-12 M 55,675 $16.31 a 1,612,277 direct yes -0.5263 1.6917 1.6917 6 -0.5639 3

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO by trust

    		2023-09-01 16:09:14 -0400 2023-08-31 G 1,095 a 176,245 indirect 1.0507 0.2251 2.364 5 0.0 1

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO by trust

    		2023-09-01 16:09:14 -0400 2023-08-30 G 141,450 a 175,150 indirect 1.0507 0.2251 2.364 5 0.0 1

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    		2023-09-01 16:09:14 -0400 2023-08-30 G 318,218 d 1,498,922 direct 1.0507 0.2251 2.364 5 0.0 1

    MIRVISS JEFFREY B. - Officer EVP&PRES, PERIPH INTERVENT

    		2023-08-30 16:10:51 -0400 2023-08-29 S 4,657 $54.50 d 60,588 direct yes -0.5933 -0.1298 0.0 1 -1.1865 3

    MIRVISS JEFFREY B. - Officer EVP&PRES, PERIPH INTERVENT

    		2023-08-30 16:10:51 -0400 2023-08-28 S 13,971 $53.14 d 65,245 direct yes -0.5933 -0.1298 0.0 1 -1.1865 3

    BROWN VANCE R - Officer SVP, GC AND CORP. SECRETARY

    		2023-08-28 16:18:24 -0400 2023-08-25 S 15,750 $50.52 d 28,578 direct yes -0.7498 -1.4996 0.0 1 -2.5238 5

    BUTCHER ARTHUR C - Officer EVP& GRP PRES, MEDSURG & APAC

    		2023-08-22 17:09:20 -0400 2023-08-21 S 6,600 $50.40 d 11,396 direct yes 0.1589 7.7855 8.5998 5 0.0 1

    DOCKENDORFF CHARLES J - Director

    		2023-08-18 16:10:51 -0400 2023-08-18 S 17,079 $50.74 d 3,946 direct yes -0.0198 6.6839 6.6839 6 -0.1388 3

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-08-15 16:16:52 -0400 2023-08-15 S 11,671 $51.30 d 62,321 direct yes -1.0105 -2.157 0.0 1 -2.4679 3

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-08-15 16:16:52 -0400 2023-08-15 M 3,448 d 13,794 direct yes

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-08-15 16:16:52 -0400 2023-08-15 M 3,448 $16.31 a 71,032 direct yes -1.0105 -2.157 0.0 1 -2.4679 3

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-08-15 16:16:52 -0400 2023-08-15 M 2,960 d 11,839 direct yes

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    		2023-08-15 16:16:52 -0400 2023-08-15 M 2,960 $13.08 a 73,992 direct yes -1.0105 -2.157 0.0 1 -2.4679 3

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    		2023-08-03 16:23:07 -0400 2023-08-02 F 487 $50.62 d 35,874 direct 0.0197 0.6112 4.4953 7.8076 18 -1.045 11

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    		2023-08-03 16:23:07 -0400 2023-08-02 M 1,090 d 2,180 direct

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    		2023-08-03 16:23:07 -0400 2023-08-02 M 1,090 a 36,361 direct 0.0197 0.6112 4.4953 7.8076 18 -1.045 11

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 22:15:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 21:45:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 21:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 20:45:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 20:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 19:45:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 19:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 18:45:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 18:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 17:45:04 UTC 0.0 0.0 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 17:15:04 UTC 0.0 0.0 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 16:45:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 16:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 15:45:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 15:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 14:45:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 14:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 13:45:03 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 13:15:04 UTC 5.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2023-09-22 12:45:04 UTC 5.07 0.25 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund BSX -7014.0 shares, $-317173.08 2019-12-31 N-PORT
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BSX -696.0 shares, $-25021.2 2020-12-31 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund BSX -303.0 shares, $-9886.89 2020-03-31 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund BSX -2706.0 shares, $-97280.7 2020-12-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund BSX -103.0 shares, $-3980.95 2021-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund BSX -2808.0 shares, $-108529.2 2021-03-31 N-PORT
    AGF Investments Trust- AGFIQ Hedged Dividend Income Fund BSX -207.0 shares, $-9168.03 2022-03-31 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund BSX -291.0 shares, $-15740.19 2023-06-30 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BSX -2476.0 shares, $-133926.84 2023-06-30 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Lois Frankel House Filing 2023-06-22 2023-05-30 P $1,001-$15,000
    Hon. Lois Frankel House Filing 2023-06-22 2023-05-31 SP $1,001-$15,000
    Hon. Lois Frankel House Filing 2023-05-19 2023-04-19 SP $1,001-$15,000
    Hon. Lois Frankel House Filing 2023-05-19 2023-05-01 SP $1,001-$15,000
    Hon. Michael T. McCaul republican House Filing 2023-05-04 2023-04-21 DC S $15,001-$50,000
    Hon. Michael T. McCaul republican House Filing 2023-05-04 2023-04-05 DC S $15,001-$50,000
    Hon. Michael T. McCaul republican House Filing 2023-05-04 2023-04-21 SP S $15,001-$50,000
    Hon. Michael T. McCaul republican House Filing 2023-05-04 2023-04-05 SP S $15,001-$50,000
    Hon. John Curtis republican House Filing 2023-05-02 2023-04-26 JT SP $1,001-$15,000
    Hon. Lois Frankel House Filing 2023-04-28 2023-03-29 SP $1,001-$15,000
    Hon. Michael T. McCaul republican House Filing 2023-04-06 2023-03-27 DC S $50,001-$100,000
    Hon. Michael T. McCaul republican House Filing 2023-04-06 2023-03-27 DC S $50,001-$100,000
    WhaleWisdom Logo

    Elevate your investments